Which statement best describes the major safety differences between SSRIs and TCAs as antidepressants?

Which statement best describes the major safety differences between SSRIs and TCAs as antidepressants?

• A. TCAs have a better safety profile with fewer anticholinergic risks.
• B. SSRIs have a better safety profile with fewer anticholinergic and cardiotoxic risks; TCAs have more anticholinergic effects and cardiotoxicity in overdose.
• C. SSRIs cause more anticholinergic effects.
• D. Both have identical safety profiles.

Answer: (B)

The main idea is the difference in safety margins, especially in overdose and anticholinergic effects. TCAs block muscarinic receptors and other cardiac ion channels, so they cause strong anticholinergic side effects (dry mouth, constipation, blurred vision, urinary retention, confusion) and can be deadly in overdose due to cardiotoxicity (arrhythmias from sodium-channel blockade). SSRIs, by contrast, mainly block serotonin reuptake and have far less impact on muscarinic receptors or cardiac conduction, so they carry far fewer anticholinergic and cardiotoxic risks overall. Some SSRIs can affect the heart at very high doses (and all antidepressants have other risks like hyponatremia or interactions that can trigger serotonin syndrome), but the general safety profile is better with SSRIs. That’s why this option best captures the major safety differences. The other statements misstate the relative safety or overgeneralize about identical risk.

The main idea is the difference in safety margins, especially in overdose and anticholinergic effects. TCAs block muscarinic receptors and other cardiac ion channels, so they cause strong anticholinergic side effects (dry mouth, constipation, blurred vision, urinary retention, confusion) and can be deadly in overdose due to cardiotoxicity (arrhythmias from sodium-channel blockade). SSRIs, by contrast, mainly block serotonin reuptake and have far less impact on muscarinic receptors or cardiac conduction, so they carry far fewer anticholinergic and cardiotoxic risks overall. Some SSRIs can affect the heart at very high doses (and all antidepressants have other risks like hyponatremia or interactions that can trigger serotonin syndrome), but the general safety profile is better with SSRIs. That’s why this option best captures the major safety differences. The other statements misstate the relative safety or overgeneralize about identical risk.